These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27480395)

  • 21. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.
    Fahelelbom KM; Al-Tabakha MM; Eissa NA; Javadi J
    Sci Pharm; 2016 Oct; 84(4):646-653. PubMed ID: 27727195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.
    Vranić E; Uzunović A
    Bosn J Basic Med Sci; 2007 Nov; 7(4):328-34. PubMed ID: 18039191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raman spectroscopy as a complementary tool to assess the content uniformity of dosage units in break-scored warfarin tablets.
    Arruabarrena J; Coello J; Maspoch S
    Int J Pharm; 2014 Apr; 465(1-2):299-305. PubMed ID: 24508332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light induced fluorescence for predicting API content in tablets: sampling and error.
    Domike R; Ngai S; Cooney CL
    Int J Pharm; 2010 May; 391(1-2):13-20. PubMed ID: 20156535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microstructural investigation to the controlled release kinetics of monolith osmotic pump tablets via synchrotron radiation X-ray microtomography.
    Li H; Yin X; Ji J; Sun L; Shao Q; York P; Xiao T; He Y; Zhang J
    Int J Pharm; 2012 May; 427(2):270-5. PubMed ID: 22366382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical Model-Based Accelerated Development of Extended-release Metformin Hydrochloride Tablet Formulation.
    Chen W; Desai D; Good D; Crison J; Timmins P; Paruchuri S; Wang J; Ha K
    AAPS PharmSciTech; 2016 Aug; 17(4):1007-13. PubMed ID: 26729531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
    Tahaineh LM; Gharaibeh SF
    J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
    Kulinowski P; Woyna-Orlewicz K; Rappen GM; Haznar-Garbacz D; Węglarz WP; Dorożyński PP
    Int J Pharm; 2015 Apr; 484(1-2):235-45. PubMed ID: 25701626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of honey locust (Gleditsia triacanthos Linn.) gum as sustaining material in tablet dosage forms.
    Uner M; Altinkurt T
    Farmaco; 2004 Jul; 59(7):567-73. PubMed ID: 15231434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix Tablets for Controlled Release of Drugs Incorporated Using Capillary Absorption.
    Maver U; Milojević M; Štos J; Adrenšek S; Planinšek O
    AAPS PharmSciTech; 2019 Jan; 20(2):91. PubMed ID: 30684053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation.
    Debunne A; Vervaet C; Mangelings D; Remon JP
    Eur J Pharm Sci; 2004 Jul; 22(4):305-14. PubMed ID: 15196587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product.
    Zaid AN; Al-Ramahi RJ; Ghoush AA; Qaddumi A; Zaaror YA
    Saudi Pharm J; 2013 Jan; 21(1):71-5. PubMed ID: 23960821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.